This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
With the rapid development of new drugs to treat human illness, the problem of adverse reactions to drugs has increased. In order to assure adequate care, the physician must have available to him the most complete and current information obtainable. To assist in providing this information, the Council on Drugs of the American Medical Association has established the Registry on Adverse Reactions.
Physicians and hospitals throughout the country are being urged to report detailed information on instances of adverse effects from drugs to the Registry. Because follow-up of these cases may be required to obtain more information from the physician, it is necessary to identify the cases. A code number is used for this purpose in order to keep the identity of the patient strictly confidential.
Obviously certain medicolegal questions arise when any program of this kind is established. Do physicians or hospitals encounter new legal risks or increase their
Bergen RP. Medicolegal Aspects of Reports on Adverse Drug Reaction. JAMA. 1965;194(9):1003. doi:10.1001/jama.1965.03090220059016
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: